The acquisition took place more than a year ago for a few tens of millions of dollars but was kept under wraps, Calcalist says; Camerai tech already in use by Apple
Swiss biopharma firm Debiopharm leads investment in Tel Aviv-based startup that uses computer vision to analyze cancer biopsies and predict drug response
Tel Aviv-based Ibex Medical Analytics will work with UK pathology firm LDPath to roll out software for England's National Health Service in bid to weed out misdiagnoses
Recent comments